These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38804143)

  • 1. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
    Daaboul D; Osman M; Kassem II; Yassine I; Girlich D; Proust A; Mounir C; Zerouali K; Raymond J; Naas T; Oueslati S
    J Antimicrob Chemother; 2024 Jul; 79(7):1614-1618. PubMed ID: 38804143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome analyses of colistin-resistant high-risk bla
    Talat A; Khan F; Khan AU
    BMC Microbiol; 2024 May; 24(1):174. PubMed ID: 38769479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Carbapenemase Encoding Gene and Resistance to Cefiderocol in Hospital and Community eXtensive Drug Resistance and Carbapenem-Resistant
    Benzaarate I; El Otmani F; Khazaz A; Timinouni M; Bourjilat F; Bogaerts P; Huang TD; Nayme K
    Foodborne Pathog Dis; 2023 Oct; 20(10):460-466. PubMed ID: 37616567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular Analysis of Antibiotic Resistance in CarbapenemResistant Pseudomonas aeruginosa Isolates Isolated from Clinical Samples].
    Altan G; Rakici E; Özgümüş OB
    Mikrobiyol Bul; 2024 Apr; 58(2):148-170. PubMed ID: 38676583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans.
    Strateva T; Keuleyan E; Peykov S
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):99-109. PubMed ID: 38857113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.
    Papagiannitsis CC; Medvecky M; Chudejova K; Skalova A; Rotova V; Spanelova P; Jakubu V; Zemlickova H; Hrabak J;
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel VIM-type metallo-beta-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit.
    Mazzariol A; Mammina C; Koncan R; Di Gaetano V; Di Carlo P; Cipolla D; Corsello G; Cornaglia G
    Clin Microbiol Infect; 2011 May; 17(5):722-4. PubMed ID: 21521413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
    Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
    PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
    Karampatakis T; Antachopoulos C; Tsakris A; Roilides E
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1211-1220. PubMed ID: 29644540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
    Liakopoulos A; Mavroidi A; Katsifas EA; Theodosiou A; Karagouni AD; Miriagou V; Petinaki E
    BMC Infect Dis; 2013 Oct; 13():505. PubMed ID: 24168643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of VIM-2 metallo-β-lactamases producing Pseudomonas aeruginosa isolates in Morocco.
    Maroui I; Barguigua A; Aboulkacem A; Ouarrak K; Sbiti M; Louzi H; Timinouni M; Belhaj A
    J Infect Chemother; 2016 Mar; 22(3):127-32. PubMed ID: 26711231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of carbapenem-resistant
    Viñes J; Lopera C; Vergara A; Roca I; Vila J; Casals-Pascual C; Martínez JA; García-Vidal C; Soriano A; Pitart C
    Microbiol Spectr; 2024 Jun; 12(6):e0061424. PubMed ID: 38727230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic epidemiology and molecular characteristics of bla
    Jung H; Pitout JDD; Matsumura Y; Strydom KA; Kingsburgh C; Ehlers MM; Kock MM
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):627-640. PubMed ID: 38265603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica.
    Toval F; Guzmán-Marte A; Madriz V; Somogyi T; Rodríguez C; García F
    J Med Microbiol; 2015 Jan; 64(Pt 1):37-43. PubMed ID: 25355933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.